Recursion Pharmaceuticals had a revenue of 14.74M in the quarter ending Mar 31, 2025, with 226.87%. This bring the company's revenue in the last twelve months to 59.76M, Decreased 1.62%. In the fiscal year ending Dec 31, 2024, Recursion Pharmaceuticals had annual revenue of 58.84M with 32.00% growth.